Somazina 100 mg / 1 ml suspension 30 ml

Tradename:

Somazina

Somazina

Composition:

Each ml of suspension contains:

Citicoline 100 mg

Properties:

Nootropic drug. Citicoline, being a precursor of key ultrastructural components of the cell membrane (mainly phospholipids), has a wide spectrum of action: it promotes the restoration of damaged cell membranes, inhibits the action of phospholipases, preventing excessive formation of free radicals, and also prevents cell death by acting on the mechanisms of apoptosis.

In the acute period of stroke, citicoline reduces the volume of damage to the brain tissue, improves cholinergic transmission.

In traumatic brain injury, it reduces the duration of post-traumatic coma and the severity of neurological symptoms, in additi citicoline helps to reduce the duration of the recovery period.

In chronic hypoxia of the brain, citicoline is effective in the treatment of cognitive disorders such as memory impairment, lack of initiative, difficulty in performing daily activities and selfcare. Increases the level of attention and consciousness, and also reduces the manifestation of amnesia.

Indications:

-Acute period of ischemic stroke (as part of complex therapy);

– the recovery period of ischemic and hemorrhagic strokes;

-craniocerebral trauma, acute (as part of complex therapy) and recovery period;

-cognitive and behavioral disorders in degenerative and vascular diseases of the brain.

Method of administration and dosage:

In case of cognitive impairment:

Adults: 500-1000 mg daily for 3 months.

Children: 500-750 mg per day for 3 months.

In case of acute and subacute disorders of cerebral circulation and when the patient can swallow:

Adults: 500-2000 mg daily for 6 weeks.

Children: 500-750 mg per day for 6 weeks.

Contraindications:

• pronounced vagotonia (predominance of the tone of the parasympathetic part of the autonomic nervous system);
• rare hereditary diseases associated with fructose intolerance;

-increased sensitivity to the components of the drug.

Precautions:

During the period of treatment, patients sh be careful when performing potentially hazardous activities that require special attention and speed of psychomotor reactions

(including driving and other vehicles, working with moving mechanisms, the work of a dispatcher and an operator).

Side effects:

Very rare (<1/10 000) (including individual cases): allergic reactions (rash, pruritus, anaphylactic shock), headache, dizziness, fever, tremors, nausea, vomiting, diarrhea, hallucinations, edema, shortness of breath, insomnia , agitation, decreased appetite, numbness in paralyzed limbs, changes in the activity of liver enzymes. In some cases, Ceraxon@ can stimulate the parasympathetic system, as well as cause a short-term change in blood pressure.

Storage method:

At a temperature not higher than 25 degrees.

Packaging:

The cardboard box holds a 30 ml bottle.